COMUNICADO: Halaven® (Eribulin) Now Available in Russia for Advanced Breast Cancer After Only One Prior Chemotherapy, Which Provides

HATFIELD, England, December 18, 2014 /PRNewswire/ —

PRESS RELEASE FOR EU MEDIA ONLY: NOT FOR SWISS/U.S. JOURNALISTS

Eisai is pleased to announce that women with locally advanced or metastatic breast cancer (MBC) in Russia will have earlier access to Halaven(R) (eribulin).

Enlace a la fuente orginal del artículo: www.europapress.es/comunicados/internacional/noticia-comunicado-halaven-eribulin-now-available-in-russia-for-advanced-breast-cancer-after-only-one-prior-chemotherapy-which-provides-20141218010224.html

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *